Table 7 Sensitivity analysis environmental burden of disease results (PAF, prevalence-based EBD [DALYs and attributable cases], and attributable health costs) of ADHD associated with exposure to pyrethroids based on the dose-response information of Lee et al. (2022)
Country | PAF (95% CI) | EBD (95% CI) [attributable cases] | EBD (95% CI) [attributable cases per 106 inhabitants] | EBD (95% CI) [DALYs] | EBD (95% CI) [DALYs per 106 inhabitants] | Attributable health costs (95% CI) [million EUR] | Attributable health costs per 106 inhabitants (95% CI) [million EUR] |
|---|---|---|---|---|---|---|---|
France | 12 (11–13) | 52,318 (28685–76314) | 788 (426–1168) | 642 (162–1091) | 10 (3–17) | 72.0 (39.5–105.0) | 1.1 (0.6–1.6) |
Iceland | 4 (1–7) | 99 (10–198) | 283 (30–567) | 1 (0–3) | 3 (0–8) | 0.2 (0.02–2.8) | 0.5 (0.05–1.0) |
Switzerland | 6 (4–7) | 2807 (1373–4503) | 315 (150–518) | 34 (10–60) | 4 (1–7) | 5.8 (2.8–9.3) | 0.7 (0.3–1.0) |
Germany | 1 (-1–3) | 2405 (-2034–6918) | 28 (-24–81) | 29 (-22–94) | 0 (0–1) | 4.0 (-3.4–11.5) | 0.05 (-0.04–0.1) |
Israel | 12 (11–12) | 9929 (5358–14002) | 1035 (547–1521) | 122 (33–216) | 13 (4–23) | 11.2 (6.1–15.8) | 1.2 (0.6–1.7) |